Australia's 4DMedical soars as US FDA clears lung diagnostic tool

4DMedical

07/01/2025 04:14

** Shares of Australia's 4DMedical  4DX.AX  rise as much as
14.7% to A$0.545, hitting their highest since early December
2024
    ** Medical technology-focussed firm says it has received
clearance from the U.S. Food and Drug Administration for its 
IQ-UIP™ product
   ** The product is an advanced AI-driven lung diagnostic tool
designed for the diagnosis of usual interstitial pneumonia
    ** Stock fell 32.9% in 2024

 (Reporting by Jasmeen Ara Shaikh in Bengaluru)
 ((Jasmeenaraislam.shaikh@thomsonreuters.com))